Poster Abstracts200 Discovery <strong>of</strong> Yersinia pestis andYersiniophage Peptide Targets forUse in Multiple Reaction MonitoringMethodsL. Luna 1 , S. Bearden 21Division <strong>of</strong> Vector-Borne Infectious Diseases,Centers for Disease Control and Prevention,Fort Collins, CO, United States; 2 Toxicology andEnvironmental Research and Consulting, The DowChemical Company, Midland, MI, United StatesAims: We present the discovery <strong>of</strong> functional yersiniophage andYersinia pestis (Y. pestis) peptide targets for monitoring bacteriophagebasedamplification processes and species-specific identification <strong>of</strong>Yersinia pestis, the etiological agent <strong>of</strong> plague. Methods: For proteinconfirmation and peptide target discovery, ultra performance liquidchromatography and hybrid tandem mass spectrometry was utilizedto identify proteolytic cleaved peptides generated from digestion <strong>of</strong>whole phage and bacterial lysates. Peptide discovery was accomplishedwith a UPLC NanoAcquity interfaced into a Q-TOF Premier (WatersCorporation) for full scan and MS/MS experiments. Targeteddevelopment utilized the MRM initiated detection and sequencing(MIDAS) workflow design s<strong>of</strong>tware (Applied Biosystems) to create insilico MRM transitions which optimized collision energies for trypsincleaved peptides from the proteins <strong>of</strong> interest. The analytical columnutilized was an UPLC bridged ethyl hybrid (BEH) 1.0 x 50 mm reversephase C18 (1.7-µm particle size) interfaced into a 4000 Q TRAP forMRM triggered MSMS. Results: We screened yersiniophage phiA1122,R, V, and Y proteins for conserved peptide targets for utilization inroutine mass spectrometry monitoring <strong>of</strong> the phage amplificationprocess. We also identified murine toxin and F1 antigen peptide targetsthat are unique to Yersinia pestis, which upon lysis, can be utilized forconfirmatory identification <strong>of</strong> Y. pestis. Conclusions: Major and minorcapsid protein peptides will serve to enhance quantifiable metricmeasurements <strong>of</strong> the amplification process for rapid yersiniophagediagnostic capabilities and concomitant determination <strong>of</strong> the presence<strong>of</strong> viable Y. pestis bacilli. Moreover, the targeted murine toxin peptidedirectly confirmed the presence <strong>of</strong> Y. pestis at 26°C and can be appliedas an additional tool for zoonosis surveillance capabilities in a clinicallaboratory setting. Significance and Impact <strong>of</strong> Study: Applicationsutilizing these peptide targets identified in this work may be beneficialin emergency response situations requiring pre**201 Protein-Binding Assays inBiological Liquids Using MicroscaleThermophoresisS. Duhr 1 , P. Baaske 1 , C. Wienken 2 ,M.J. Willemsen 2 , D. Braun 21NanoTemper Technologies GmbH, and Centerfor Nanoscience, University Munich, Munich,Germany; 2 University Munich, Physics Department,Munich, GermanyProtein interactions inside the human body are expected to differ fromthe situation in vitro. This is crucial when investigating protein functionsor developing new drugs. In this study, we present a sample-efficient,free-solution method, termed Microscale Thermophoresis (MST), thatis capable <strong>of</strong> analysing interactions <strong>of</strong> proteins or small molecules inbiological liquids such as blood serum or cell lysate. The technique isbased on the thermophoresis <strong>of</strong> molecules, which provides informationabout molecule size, charge and hydration shell. We validated themethod using immunologically relevant systems including humaninterferon gamma and the interaction <strong>of</strong> calmodulin with calcium. Theaffinity <strong>of</strong> the small-molecule inhibitor quercetin to its kinase PKA wasdetermined in buffer and human serum, revealing a 400-fold reducedaffinity in serum. This information about the influence <strong>of</strong> the biologicalmatrix may allow to make more reliable conclusions on proteinfunctionality, will facilitate more efficient drug development, and mayallow for sensitive diagnostics in complex biological samples.202 2-D DIGE Analysis <strong>of</strong> MulticellularTumor Spheroids in Evaluation <strong>of</strong>Breast Cancer TreatmentV. Ruddat 1 , M. Winkvist 2 , S. Grimsby 2 ,A. Monazzam 3 , K. Nyamekye 3 ,Å. Hagner-McWhirter 21GE Healthcare, Piscatway, NJ, United States; 2 GEHealthcare Bio-Sciences AB, Uppsala, Sweden;3Uppsala Applied Science Lab, GE Healthcare,Uppsala, SwedenMany cancers can be diagnosed using positron emission tomography(PET) and PET can also be used to monitor how effective varioustreatments are in individual patients. Tumor spheroids are cancer cellsgrown on agar coated dishes forming a 3D structure. They are widelyused in preclinical cancer research, where the multicellular tumorspheroid model is considered biologically and physiologically similarto in vivo grown tumors. In this study we have used Two-dimensionalDifference Gel Electrophoresis (2-D DIGE) analysis to gain more insightin differences in protein expression as a result <strong>of</strong> drug treatment<strong>of</strong> multicellular tumor spheroids. 2-D DIGE can be used to identifypossible new biomarkers for development <strong>of</strong> new PET tracers and drugtargets. Combining 2-D DIGE and PET results can be used for improvingdiagnosis and treatment.203 N-Glycosylation <strong>of</strong> AntibodiesCharacterized by Mass Spectrometry:An Integrated S<strong>of</strong>tware ApproachU. Schweiger-Hufnagel, A. Asperger,A. Resemann, D. SuckauBruker Daltonics, Bremen, GermanyAntibodies represent one <strong>of</strong> the most important classes <strong>of</strong>glycoproteins playing a central role in the immune response <strong>of</strong> livingorganisms. Furthermore, there is a growing interest in recombinantantibodies as potential biotherapeutic agents. The analysis <strong>of</strong> theN-glycosylation pattern present on antibodies is challenging due to itsheterogeneous structure. The glycan pr<strong>of</strong>ile is highly dependent onthe process by which a recombinant glycoprotein is generated, suchas host organism and growth conditions. Changes to the glycosylationpattern can significantly alter biological function. To characterize theN-glycosylation pattern <strong>of</strong> a recombinant antibody, a bottom-upapproach was pursued. Tryptic digests <strong>of</strong> antibody samples wereseparated by nano-LC and analyzed by MALDI mass spectrometry. Anintegrated s<strong>of</strong>tware approach allowed a detailed characterization <strong>of</strong>the glycosylation pattern and visualization <strong>of</strong> the relevant mass spectra.LC-MALDI-TOF/TOF analysis <strong>of</strong> the digested antibody provided,in addition to the nearly complete sequence coverage <strong>of</strong> the nonglycosylatedpeptides, a detail-rich picture <strong>of</strong> the highly complex88 • <strong>ABRF</strong> <strong>2011</strong> — Technologies to Enable Personalized Medicine
pattern <strong>of</strong> N-linked glycans in form <strong>of</strong> the respective N-glycopeptides.Targeted analysis <strong>of</strong> potential glycopeptides significantly increased theinformation content. Integrated glycoprotein analysis s<strong>of</strong>tware tools(ProteinScape 2.2) allowed identification <strong>of</strong> glycan modifications andinteractive result validation. In this process s<strong>of</strong>tware facilitated theinitial characterization <strong>of</strong> the antibody as well as the subsequent qualitycontrol tasks.204 Magnetic ZIC-HILIC BeadsEnrichment for Neutral and AcidicGlycopeptidesA. Resemann 1 , J. Wohlgemuth 2 , S. Andrecht 2 ,A. Schneider 1 , U. Schweiger-Hufnagel 1 , D. Suckau 11Bruker Daltonics, Bremen, Germany; 2 Merck KGaA,Darmastadt, GermanyGlycosylation is the most abundant protein posttranslational modificationand is involved in many relevant biological processes and crucial to theunderstanding <strong>of</strong> many diseases. In depth analysis <strong>of</strong> glycosylationsites is difficult, however, as glycopeptides exhibit a significant microheterogeneity at glycosylation sites. In addition, ion suppressioneffects require selective methods for glycopeptide enrichment. Massspectrometric analysis <strong>of</strong> glycopeptides is challenging because boththe peptide as well as the glycan moiety have to be elucidated for a fullstructural understanding. We used Fetuin, Asialo-Fetuin and Alpha-1-Acidglycoprotein to equally representing sialylated and non-sialylatedglycosylic structures. In addition, monoclonal antibodies were analyzedas a dedicated example for pharmaceutical QC. Proteins were digestedwith trypsin and glycopeptides were enriched using a dedicated ZIC-HILIC glycocapture beads in combination with an optimized buffersystem (EMD Chemicals Inc.). The glycopeptides were analyzed usingESI ion trap MS for glycopr<strong>of</strong>iling and MALDI-TOF/TOF-MS for indepth characterization <strong>of</strong> the glycopeptides. For database searches,an integrated s<strong>of</strong>tware approach was used: protein searches <strong>of</strong> theglycopeptide MS/MS spectra were performed for obtaining the aminoacid sequence <strong>of</strong> the glycopeptide, and searches in glycan databasesbased on the same glycopeptide MS/MS spectra were carried outto complete the characterization <strong>of</strong> N-linked glycopeptides. In thecurrent study, two important features <strong>of</strong> glycoprotein analysis areshown: (1) The employed integrated s<strong>of</strong>tware approach allowed theglycan identification in a similar way as peptide identification. Theimportant step <strong>of</strong> interactive result validation was facilitated by a suite<strong>of</strong> dedicated data and result viewers. (2) Compared to MS analysis <strong>of</strong>native glycoprotein digests, the enriched samples allowed to detectmore glycopeptides and permitted the acquisition <strong>of</strong> higher qualityMS/MS spectra. For MALDI-TOF/TOF-MS analysis, linear positive ionmode detection <strong>of</strong> precursor ions proved to be highly suitable for theanalysis <strong>of</strong> even multi-sialylated glycopeptides.205 Fragment Analysis <strong>of</strong> CarbohydratesFollowing Capillary ElectrophoresisT. Snyder-Leiby, D. Hulce, F. Li, X. Li, C.S. LiuS<strong>of</strong>tGenetics, LLC, State College, PA, United StatesDepending on the macromolecule size and configuration, migrationrates through capillary electrophoresis vary greatly. Internal sizestandards for capillary electrophoresis <strong>of</strong> the same macromolecule maynot be readily available. The Macromolecule Tool in GeneMarker®aids with analysis <strong>of</strong> macromolecule fragments without an internallane size standard. Methods included importing raw data files to thes<strong>of</strong>tware and physically identifying reference peaks in the samplesknown to have the same size. The program uses this information tocalibrate from one capillary to another. Characteristics <strong>of</strong> the aligneddata (such as relative size, peak height, peak area, peak ratios) wereexported in an excel sheet. Ninety six raw data files from 4 dye capillaryelectrophoresis were analyzed. Peak height, height ratio, area, arearatio, and relative sizes were determined for all samples. These valuescan be used to determine characteristics such as number and relativesize <strong>of</strong> degradation products or other macromolecules, such as DNAbinding carbohydrates commonly functioning in gene regulation.206 Analysis <strong>of</strong> Complex Oligosaccharidesfrom Glycopeptides andGlycoproteins Using MSn Spectra andOligosaccharides Spectral LibraryF. XiangShimadzu Biotech, Pleasanton, CA, United StatesGlycosylation is a common post-translational modification to cellsurface and extra cellular matrix proteins as well as to lipids. Unlikeproteins and nucleic acids that are linear polymers <strong>of</strong> amino acidsand nucleotides respectively, with linkages at only one position,carbohydrates can adopt complex branched structures with individualmonomeric units linked at one <strong>of</strong> several sites. A detailed analysis<strong>of</strong> complex carbohydrate structures has been explored with massspectrometric techniques, and still presents challenge for the analyst.This presentation will describe a systematic approach <strong>of</strong> carbohydratesand glycoconjugates analysis with MSn techniques. Oligosaccharides,cleaved from glycoproteins (by hydrazinolysis or enzymatically), werecharacterized using a hybrid MALDI Ion Trap / TOF mass spectrometer.High mannose, biantennary and triantennary oligosaccharides wereanalyzed using MS, NS2, MS3 and MS4 modes. Intact oligosaccharideswere analyzed in MS mode using a cooling gas to prevent fragmentation.Individual precursor ions were isolated in the trap, subjected t<strong>of</strong>ragmentation with Argon, to provide MS2 data. Product ions wereselected for further fragmentation, which was achieved by increasingthe energy for collisionally induced dissociation. In MS mode, the singlycharged sodium adduct form <strong>of</strong> these molecules was detected, whichis typical <strong>of</strong> the analysis on conventional MALDI mass spectrometers.In MS2 mode, high mannose oligosaccharides readily lost the coreN-acetylglucosamine residues, whilst MS3 and MS4 modes were usedto sequentially fragment the product ion corresponding to the residualbranched mannose oligomer. In MS2 mode analysis <strong>of</strong> biantennaryand triantennary structures also fragmented losing disaccharide units,such as the galactose - N - acetylglucosamine units that define eachantennary branch, or core fucosylated - N - acetylglucosamine units.MS3 <strong>of</strong> selected MS2 products ions could be used to differentiatefragments generated from either the reducing or non-reducing ends.Cross-ring cleavages were also observed during fragmentation in MS2,and the relevant product ions could be used to differentiate branchedstructures by further fragmentation in MS3 mode. Many tandem massspectrometric experiments have been revealing that oligosaccharidesmight have characteristic signal intensity pr<strong>of</strong>iles, depending on theglycosidic linkage and branching structures. In addition to the MSncapability <strong>of</strong> the platform, there is a library <strong>of</strong> observational mass spectraacquired from structurally defined oligosaccharides. The presentationwill show the enhancement <strong>of</strong> carbohydrate identification by utilizingcomparison procedure <strong>of</strong> the signal intensity pr<strong>of</strong>iles <strong>of</strong> MSn spectrabetween the analyte and structurally defined oligosaccharides in thelibrary.Poster Abstracts<strong>ABRF</strong> <strong>2011</strong> — Technologies to Enable Personalized Medicine • 89
- Page 7 and 8:
Meeting SponsorsThe Association of
- Page 9 and 10:
Registration ServicesRegistration S
- Page 12 and 13:
Presenter InformationPresenter Info
- Page 14 and 15:
AwardsABRF Annual Award for Outstan
- Page 16 and 17:
ABRF Robert A. Welch Outstanding Re
- Page 18 and 19:
Program-at-a-GlanceProgram-at-a-Gla
- Page 20 and 21:
Sunday, February 20 (Continued)(S1-
- Page 22 and 23:
Sunday, February 20 (Continued)(W3-
- Page 24 and 25:
Monday, February 21 (Continued)12:0
- Page 26 and 27:
Tuesday, February 22 (Continued)9:0
- Page 28 and 29:
Tuesday, February 22 (Continued)(W1
- Page 30 and 31:
Satellite Educational Workshop Spon
- Page 32 and 33:
SW2: An Introduction to Metabolomic
- Page 34 and 35:
SW4: Lean Management in Core Facili
- Page 36 and 37:
Plenary Session AbstractsPlenary Se
- Page 38 and 39:
Scientific Session AbstractsScienti
- Page 40 and 41: Scientific SessionAbstractsstatisti
- Page 42 and 43: Scientific SessionAbstracts(S5) Hig
- Page 44 and 45: Scientific SessionAbstracts(S7-2) S
- Page 46 and 47: Workshop Session AbstractsWorkshop
- Page 48 and 49: Workshop SessionAbstractscase incor
- Page 50 and 51: Workshop SessionAbstracts(W7) Cellu
- Page 52 and 53: Workshop SessionAbstractsresolution
- Page 54 and 55: (W14-3) Galaxy Next Generation Sequ
- Page 56 and 57: Research Group Presentation Abstrac
- Page 58 and 59: Research GroupPresentation Abstract
- Page 60 and 61: Research GroupPresentation Abstract
- Page 62 and 63: Poster Session Abstracts**ABRF Post
- Page 64 and 65: Poster Abstractsglobal gene express
- Page 66 and 67: Poster Abstractsdiscussions of cont
- Page 68 and 69: Poster Abstractspossible applicatio
- Page 70 and 71: Poster Abstracts129 Bravo Automated
- Page 73 and 74: distribution. Additionally, we show
- Page 75 and 76: Illumina Genome Analyzer. PicoPlex
- Page 77 and 78: uniformity, reproducibility of enri
- Page 79 and 80: kits for Tempus TM and PAXgene® st
- Page 81 and 82: 165 Benchmarking miRNA ExpressionLe
- Page 83 and 84: Phoenix crystallography robot and a
- Page 85 and 86: Laboratory is located next door and
- Page 87 and 88: data of a Thermo Orbitrap instrumen
- Page 89: **197 Multi-Functional Superparamag
- Page 93 and 94: advantage of using two separate 15
- Page 95 and 96: allowed absolute quantitation. Comp
- Page 97 and 98: levels between the animal groups. A
- Page 99 and 100: MuDPIT, and off-gel electrophoresis
- Page 101 and 102: 237 Multi-Site Assessment of Proteo
- Page 103 and 104: with good limits of quantification
- Page 105 and 106: 249 Rapid Monoclonal Antibody Glyca
- Page 107 and 108: OOng, J. - 117PPatel, S. - 169Peake
- Page 109 and 110: AnaSpec, Eurogentec Group Booth 417
- Page 111 and 112: FASEB MARC Program Booth 4169650 Ro
- Page 113 and 114: IntegenX, Inc. Booth 2015720 Stoner
- Page 115 and 116: Nonlinear Dynamics Booth 1052530 Me
- Page 117 and 118: Roche Applied Science Booth 5009115
- Page 119 and 120: Exhibit Hall FloorplanGrand Oaks Ba
- Page 121 and 122: Exhibitor List in Booth OrderExhibi
- Page 123 and 124: This workshop will present ways to
- Page 125 and 126: Grand Oaks Ballroom,Rooms P&Q, Leve
- Page 127 and 128: NotesNotesABRF 2011 — Technologie
- Page 129 and 130: Tuesday, February 22 — 12:00 pm -
- Page 131 and 132: MARCH 16-20, 2012 • DISNEY’S CO